Form 8-K - Current report:
SEC Accession No. 0001358403-16-000161
Filing Date
2016-04-06
Accepted
2016-04-06 16:34:58
Documents
1
Period of Report
2016-03-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K ITEM 5.02 AGREEMENT a8-kslawinagreement.htm 8-K 30256
  Complete submission text file 0001358403-16-000161.txt   31536
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

EIN.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 161557836
SIC: 2834 Pharmaceutical Preparations